Tests tranexamic acid to reduce bleeding during gastric bypass surgery in adults with obesity
Tests tranexamic acid during gastric bypass surgery in adults with severe obesity.
Plain-language title generated from the registry record
Registry title: Peroperative Administration of Tranexamic acid in gastric bypass to reduce haemorrhage in patients with morbid obesity
Key facts
- Where
- Almelo, Amsterdam, Arnhem, Heerlen, Rotterdam, and Tilburg, NetherlandsSee the 6 sites
- Phase
- Phase 3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Source: NCT05464394, who can take part
Where in Netherlands
- Ziekenhuisgroep Twente StichtingAlmelo, NetherlandsTaking people
- Stichting OLVGAmsterdam, NetherlandsTaking people
- Rijnstate Ziekenhuis StichtingArnhem, NetherlandsTaking people
- Zuyderland Medisch Centrum StichtingHeerlen, NetherlandsTaking people
- Sint Franciscus Vlietland Groep StichtingRotterdam, NetherlandsTaking people
- Elisabeth-Tweesteden ZiekenhuisTilburg, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sint Franciscus Vlietland Groep Stichting
- Trial code
- NCT05464394EU 2024-513570-22-00
- Record updated
- 22 July 2024
- Original description
This trial aims to investigate whether peroperative administration of TXA reduces haemorrhage rates in patients who undergo gastric bypass surgery.Read full original descriptionShow less
Peroperative Administration of Tranexamic acid in Roux-en-Y and one-anastomosis gastric bypass to reduce haemorrhage (PATRY study): a randomized controlled trial
This trial aims to investigate whether peroperative administration of TXA reduces haemorrhage rates in patients who undergo gastric bypass surgery.
Inclusion: Patients aged 18 years or older, eligible for bariatric surgery according to the IFSO guidelines and undergoing a laparoscopic (Roux-en-Y or one-anastomosis) gastric bypass.
Exclusion: Patients unwilling to give informed consent, patients with a medical history of bleeding or venous thromboembolism and patients that use anticoagulants will be excluded.